CAS 125116-23-6: Metconazole

Applications Metconazole is a conazole based fungicide used for the control of black sigatoka disease on bananas. Metconazole acts primarily as an inhibitor of ergosterol biosynthesis which interferes with the synthesis of fungal cell membranes. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Cools, H.J., et al.: Pest. Manage. Sci., 68, 1034 (2012); Nam, M.H., et al.: Res. Plant. Disease., 17, 295 (2011);

Metconazole is a triazole antifungal drug with systemic activity. It inhibits the synthesis of ergosterol and other sterols, which are essential for fungal cell membranes. Metconazole has been shown to have synergistic effects when combined with other fungicides in a lc-ms/ms method for analysis of terminal residues in wheat. The most frequent adverse effect of metconazole treatment is photosensitivity. Metconazole has been studied extensively for its potential carcinogenic properties, but there is no conclusive evidence that it causes cancer in humans or animals. There have been conflicting results from studies on the carcinogenic potential of metconazole.